Summary: “Six years ago, Rogan’s interview with Rick Doblin, founder and executive director of the Multidisciplinary Association for Psychedelic Studies (MAPS), presented an early, sneak peek at the long-term research being conducted on MDMA (aka, ecstasy) to treat PTSD,” explains Forbes in an article exploring the archive of interviews between psychedelic pioneers and Joe Rogan on his podcast, The Joe Rogan Experience. maps.org/jrepodcast
Originally appearing here.
